Deinove a biotechnology company that discovers, develops and produces compounds with high added value from rare bacteria, and Greentech, a major player in the production and distribution of active ingredients derived from biotechnology, have launched HEBELYS, the first anti-aging active ingredient resulting from the collaboration launched in March 2017.

This anti-aging active ingredient is obtained by fermentation of a Sphingomonas bacterium, a rare microorganism coming from the Deinove strain library. 

In tests, HEBELYS preserved youthful skin, acting on different parameters: protection against oxidation, stimulation of collagen, elastin, and fibrillin synthesis. HEBELYS has, in particular, a significant and proven action on the expression of the p16(IINK4A) protein, a key factor of premature cellular aging. Under the effect of HEBELYS, skin is protected, regaining density, suppleness, and elasticity.

HEBELYS is the first active ingredient resulting from the collaboration between Deinove and Greentech. Deinove selected the strain, developed the production process to achieve optimal fermentation performances, and supervised the in vitro tests intended to characterize the extract; Greentech developed the formulation process, and validated the stability and the safety, as well as the efficiency, by additional ex vivo tests.

Jean-Yves Berthon, CEO of Greentech, stated: “This first collaboration is a real success. HEBELYS is a truly great active ingredient, fully in line with our catalog and our ambition to offer the cosmetic industry high-tech active ingredients.”

Emmanuel PETIOT, CEO of Deinove added: “The joint work of both teams has been very rewarding.   We are proud to have responded to Greentech’s expectations in terms of innovation and achieved a commercial product so quickly. We intend to continue in this direction.”